Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Verona Pharma PLC American Depositary Share (VRNA) had Normalized Pre-Tax Income of $11.88M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$103.14M |
|
$11.92M |
|
$4.76M |
|
$98.38M |
|
$89.83M |
|
$13.30M |
|
$-1.42M |
|
$11.88M |
|
|
Normalized Pre-Tax Income |
$11.88M |
$11.92M |
|
$11.92M |
|
$11.92M |
|
$11.92M |
|
$13.30M |
|
$14.29M |
|
85.64M |
|
90.90M |
|
$0.14 |
|
$0.13 |
|
| Balance Sheet Financials | |
$548.85M |
|
$0.99M |
|
$24.02M |
|
$572.87M |
|
$51.24M |
|
$242.43M |
|
$243.36M |
|
$294.60M |
|
$278.27M |
|
$277.73M |
|
$278.27M |
|
85.99M |
|
| Cash Flow Statement Financials | |
$19.00M |
|
$-0.54M |
|
$18.40M |
|
$399.76M |
|
$438.02M |
|
$38.26M |
|
$72.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.71 |
|
-- |
|
-- |
|
0.47 |
|
0.87 |
|
95.39% |
|
12.90% |
|
12.90% |
|
-- |
|
11.52% |
|
11.56% |
|
$18.46M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.55 |
|
1.19 |
|
75.85 |
|
4.28% |
|
4.29% |
|
2.08% |
|
2.29% |
|
$3.24 |
|
$0.20 |
|
$0.21 |
|